Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more

Oak Longevity

Budget Compounded (3-Month Code Pricing) + Brand Retail

From $133–$1400/mo

Compounded semaglutide $133/mo and tirzepatide $199/mo on a 3-month supply with Oak's checkout code ($200/$250 month to month), no membership; brand-name GLP-1s also sold at retail-level prices

Visit Oak Longevity →

Pros

  • No membership fee and non-recurring billing: you choose whether to renew each month, with free shipping and health coaching included
  • Compounded semaglutide $133/mo and tirzepatide $199/mo on a 3-month supply when Oak's checkout code (OAKSAVE200) is applied; $200 / $250 month to month
  • Board-certified Obesity Medicine CMO (Michael Regan, MD); NVP Medical Group infrastructure shared with Wisp and Ro
  • Async intake with no mandatory video visit for initial approval; same-day approval advertised
  • Also stocks brand-name Wegovy, Zepbound, Ozempic, and Mounjaro for patients who want an FDA-approved product from the same platform

Cons

  • Compounded medications are not FDA-approved as finished products
  • The $133/$199 headline requires a 3-month supply billed upfront plus a promo code; month to month is $200 (semaglutide) or $250 (tirzepatide)
  • The checkout FAQ says each dose step-up costs roughly $50 to $75 more, contradicting the "one price, all dosages" banner; confirm the escalation policy before you rely on a flat rate
  • Brand-name GLP-1s are priced at retail level ($1,100 to $1,400/mo), far above the manufacturer self-pay programs
  • Not available in West Virginia or Mississippi; compounding pharmacy partner is not named publicly
  • Customer service is contracted separately from the prescribing medical group; some reviewers report delays when issues arise

Details

Medications offered
Compounded Sema, Compounded Tirz, Mounjaro, Ozempic, Zepbound, Wegovy
State availability
Not all states — confirm before starting
Affiliate partnership
Yes
Data verified
2026-09-01